Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

Bibliographic Details
Main Authors: Biondi, Andrea, Schrappe, Martin, De Lorenzo, Paola, Castor, Anders, Lucchini, Giovanna, Gandemer, Virginie, Pieters, Rob, Stary, Jan, Escherich, Gabriele, Campbell, Myriam, Li, Chi-Kong, Vora, Ajay, Aricò, Maurizio, Röttgers, Silja, Saha, Vaskar, Valsecchi, Maria Grazia
Format: Online
Language:English
Published: Lancet Pub. Group 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431502/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431502/

Similar Items